stage ia pancreatic cancer ajcc v8

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

Recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +5 more
  • Durvalumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage

Recruiting
  • Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
  • +85 more
  • Patient Monitoring System
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Sep 7, 2022

Borderline Resectable Pancreatic Carcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma, Resectable Pancreatic

Recruiting
  • Borderline Resectable Pancreatic Carcinoma
  • +8 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Aug 25, 2022

Resectable Pancreatic Ductal Adenocarcinoma, Stage 0 Pancreatic Cancer AJCC v8, Stage I Pancreatic Cancer AJCC v8 Trial in

Recruiting
  • Resectable Pancreatic Ductal Adenocarcinoma
  • +7 more
  • Pyrvinium Pamoate
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 1, 2022

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal

Recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +11 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Mar 22, 2022

Heart Rate Variability for Early Detection of Pancreatic Cancer

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Activity Monitor
  • +2 more
  • Omaha, Nebraska
  • +2 more
Mar 5, 2022

Pancreatic Ductal Adenocarcinoma, Colorectal Adenocarcinoma, Gastric Adenocarcinoma Trial in Philadelphia (Adenovirus

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +37 more
  • Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Nov 2, 2021